Latest Strategy News

Avira Resources has cleared all major regulatory and heritage hurdles to kick off a 4,500-metre RC drilling campaign at its high-grade Mt Cattlin Gold Project, aiming for a maiden resource estimate by year-end.

Condor Energy secures A$2.25 million in a placement to advance licence conversion, gas commercialisation, and exploration drilling readiness in its offshore Peru portfolio.

American West Metals (ASX: AW1) has raised A$10 million through an oversubscribed institutional placement to fast-track exploration at its West Desert and Storm Copper projects, focusing on high-demand critical metals.

Ronin Resources reports elevated gold, silver, copper, and tungsten values from rock-chip sampling at its La Punilla Project in Argentina, supported by a drone aeromagnetic survey revealing a coincident magnetic source. Follow-up fieldwork is underway to expand and validate these early-stage porphyry copper-gold exploration targets.

SSH Group Ltd is set to acquire Elphinstone Mechanical Services, boosting its revenue scale and geographic reach into Queensland and New South Wales with an immediately accretive deal.

Imricor Medical Systems has secured A$60 million through a placement to fund its US commercial rollout, regulatory approvals, and clinical programs, boosting its cash reserves to nearly A$103 million.

Gorilla Gold Mines has uncovered a new high-grade gold lode at the Sovereign Deposit within its Comet Vale Gold Project, intersecting 9.3m at 20.6g/t Au in a previously untested footwall position. This discovery adds a fresh dimension to the North Kalgoorlie Hub’s 1.2Moz resource base and accelerates the company’s exploration momentum.

Sunstone Metals has extended gold-copper mineralisation at its Bramaderos project in Ecuador, with recent drill holes intersecting significant widths that support upgrading a large exploration target into resources.

Vanadium Resources raises about A$1 million through a placement to fund studies and site agreements for its Steelpoortdrift Vanadium Project and next-gen V-Iron Plant, aiming to supply Western critical mineral markets.

Entropy Neurodynamics has unveiled a striking 75% response rate in a small Phase 2a trial of its oral psilocybin therapy for treatment-resistant irritable bowel syndrome, far surpassing existing treatments and validating its gut-brain axis approach.

Cynata Therapeutics has secured A$1.5 million through an institutional placement priced at a 22.5% discount, aiming to extend its cash runway ahead of pivotal Phase 3 and Phase 2 trial results expected in May and June 2026.

BrainChip Holdings has signed a global IP license agreement with ASICLAND, enabling integration of its Akida neuromorphic AI technology into custom SoC designs with a royalty-based revenue model.